Drug-pathway Mapping
Drug-Pathway Mapping is a computational method that identifies and establishes associations between pharmaceutical compounds and biological pathways by integrating molecular interaction data, thereby enabling the systematic inference of drug mechanisms and therapeutic repurposing opportunities.
71
Publications
5.6K
Citations
364
Authors
172
Institutions
Publications per year
2017–2026
29
Parents
71
1–5 of 71
364
2
h-index
2
h-index
2
h-index
National Technical University of Athens, Greece
2 publications · 190 citations
2
h-index
2
h-index
1–5 of 364
172
Massachusetts Institute of Technology
Cambridge, United States
3 h-index
4 publications
457 citations

European Bioinformatics Institute
Cambridge, United Kingdom
3 h-index
7 publications
184 citations
Institució Catalana de Recerca i Estudis Avançats
Barcelona, Spain
3 h-index
5 publications
183 citations
Tufts University
Medford, United States
2 h-index
3 publications
153 citations
Harbin Medical University
Harbin, China
2 h-index
14 publications
326 citations
National University of Singapore
Singapore, Singapore
2 h-index
6 publications
1.6K citations
Institute for Research in Biomedicine
Barcelona, Spain
2 h-index
7 publications
335 citations
University of Pittsburgh
Pittsburgh, United States
2 h-index
9 publications
219 citations
1–8 of 172
7 publications · 319 citations
7
h-index
JCIM · 5 publications · 264 citations
5
h-index
4 publications · 187 citations
4
h-index
3 publications · 108 citations
3
h-index
2 publications · 27 citations
2
h-index
1–5